Loading clinical trials...
Loading clinical trials...
IGIV-C 10% Rapid Infusion Trial in Primary Immune Deficient Patients
Conditions
Interventions
Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified
Dextrose, 5% in Water
Locations
13
United States
Departments of Medicine and Microbiology
Birmingham, Alabama, United States
National Jewish Medical and Researach Center
Denver, Colorado, United States
International Center for Interdisciplinary Studies of Immunology
Washington D.C., District of Columbia, United States
Allergy Associates of the Palm Beaches
North Palm Beach, Florida, United States
University of South Florida College of Medicine
St. Petersburg, Florida, United States
The Clinical Trials Center, Children's Hospital
New Orleans, Louisiana, United States
Start Date
August 1, 2002
Primary Completion Date
August 1, 2002
Completion Date
March 1, 2004
Last Updated
September 25, 2009
NCT02417740
NCT04049084
NCT01852370
NCT06731036
NCT00695279
NCT01129544
Lead Sponsor
Grifols Therapeutics LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions